Volume 24, Number 5—May 2018
Research Letter
Bartonella henselae DNA in Seronegative Patients with Cat-Scratch Disease
Table
Patient no. |
Patient age, y/sex |
Fever |
Regional lymphadenopathy |
History of contact with animal |
IFA titer | Cp of rPCR,
mean ± SD |
Complication |
|
---|---|---|---|---|---|---|---|---|
IgM |
IgG |
|||||||
1 | 15/M | + | + | Cat, dog | 40 | 256 | NA | |
2 | 4/F | + | – | Cat | 20 | 512 | 36.82 ± 0.57 | FUO |
3 | 6/F | + | – | Dog | <10 | 64 | 33.93 ± 0.39 | FUO |
4 | 13/M | + | + | Cat | <10 | 256 | 35.98 ± 0.69 | |
5 | 14/F | + | + | Cat, dog | <10 | 256 | 34.29 ± 0.43 | |
6 | 8/M | + | + | Dog | <10 | <64 | 35.35 ± 0.33 | |
7 | 10/M | + | + | Cat | 20 | 256 | NA | |
8 | 8/F | + | + | Dog | <10 | <64 | 37.18 ± 0.36 | |
9 | 10/M | + | + | Cat | 20 | 256 | NA | |
10 | 7/F | + | + | Cat | 10 | <64 | 35.64 ± 0.27 | |
11 | 2/M | + | + | Cat | 40 | 256 | NA | |
12 | 15/M | + | – | Cat, dog | >80 | 512 | NA | Neuroretinitis |
13 | 6/F | + | + | Cat | <10 | 256 | 37.29 ± 0.15 | |
14 | 10/M | + | + | Cat | <10 | 256 | NA | |
15 | 12/F | + | + | Cat, dog | <10 | 512 | 33.55 ± 0.33 | |
16 | 13/M | + | – | Cat | <10 | 512 | NA | FUO |
17 | 9/F | + | + | Cat | <10 | <64 | 34.84 ± 0.47 | |
18 | 4/M | + | + | Cat | 20 | 512 | NA | |
19 | 14/F | + | – | Dog, rabbit | 80 | 512 | NA | Neuroretinitis |
20 | 56/F | + | – | Cat | <10 | 256 | NA | Neuroretinitis |
21 | 35/F | + | + | Cat | 40 | 1,024 | 37.19 ± 0.59 | |
22 | 7/M | + | + | Cat, dog | <10 | 512 | NA |
*Blank cells indicate no complications. Cp, crossing point value; FUO, fever of unknown origin; IFA, indirect fluorescent antibody test; NA, no amplification by rPCR; rPCR, real-time PCR; +, positive; –, negative.
Page created: April 17, 2018
Page updated: April 17, 2018
Page reviewed: April 17, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.